Erector Spinae Plane Block and Ankle and Foot Surgery
Pain, Ankle Injuries
About this trial
This is an interventional prevention trial for Pain focused on measuring Erector spinae block, Ankle and foot surgery, Postoperative analgesia
Eligibility Criteria
Inclusion Criteria: Age 18 - 65 years, American Society of Anesthesiologists physical status classification Ι and ΙΙ; scheduled for ankle and foot surgery Exclusion Criteria: Major hepatic severe renal impairment (creatinine > 3 or on dialysis); severe cardiovascular disease (ejection fraction < 35%) local infection at site of injection Any contraindication for ESP Known allergy to any drug used in the study
Sites / Locations
- Fayoum University hospital
Arms of the Study
Arm 1
Arm 2
Sham Comparator
Experimental
Control group
ESP group
The control group underwent US-guided sham block at L4 vertebrae level with 20 ml of saline 0.9%. At the level of L4 and after skin sterilization, sham block was administered in a sitting position. Hydro dissection of the interfascial plane between the erector spinae muscle and TP was confirmed by visualizing the local anesthetic spreading in a linear pattern between the muscle and the bony acoustic shadows of the TP. Then, up to 20 ml Saline 0.9% was injected.
The ESP group underwent US-guided ESP block at L4 vertebrae level with 20 ml of bupivacaine 0.25%. After skin sterilization, ESP block was administered in a sitting position. A linear US transducer was placed vertically 3 cm lateral to the midline to visualize back muscles: the trapezius above, the rhomboid major in the middle, and the erector-spinae muscle on the bottom, as well as the TPs with shimmering pleura in between. Next, 2-3 ml of 2% lidocaine was infiltrated. Hydro dissection of the interfascial plane between the erector spinae muscle and TP was confirmed by visualizing the local anesthetic spreading in a linear pattern between the muscle and the bony acoustic shadows of the TP.